Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation.

Angelidou, Asimenia; Conti, Maria-Giulia; Diray-Arce, Joann; Benn, Christine S; Shann, Frank; Netea, Mihai G; Liu, Mark; Potluri, Lakshmi Prasad; Sanchez-Schmitz, Guzman; Husson, Robert; +4 more... Ozonoff, Al; Kampmann, Beate; van Haren, Simon Daniël; Levy, Ofer; (2020) Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. VACCINE, 38 (9). pp. 2229-2240. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2019.11.060

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2019.11.060

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID 32005538
Elements ID 144275

Share

Download

Filename: 1-s2.0-S0264410X19316147-main.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar